No Excess Pregnancy, Infant Risks With Ocrelizumab for MS
Women with multiple sclerosis (MS) who were treated with ocrelizumab (Ocrevus) had no increased risk of adverse pregnancy and infant outcomes, prospective data showed. Cumulative data did not suggest an increased risk of preterm birth, major congenital anomalies, or other adverse outcomes with ocrelizumab in utero exposure and were consistent with epidemiological data, reported Celia […]
At risk for diabetes? Cut the carbs, says new study
While low-carb diets are often recommended for those being treated for diabetes, little evidence exists on whether eating fewer carbs can impact the blood sugar of those with diabetes or prediabetes who aren’t treated by medications. Now, according to new research from Tulane University, a low-carb diet can help those with unmedicated diabetes — and […]
Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer
SAN ANTONIO — A study of men treated in Veterans Health Administration facilities suggested that lower prostate-specific antigen (PSA) screening rates were associated with subsequent increased rates of metastatic prostate cancer. Across 128 facilities, PSA screening rates declined from 47% in 2005 to 37% in 2019, which was observed across all ages and races, reported […]
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL
SAN ANTONIO — Men with intermediate- and high-risk prostate cancer treated with external-beam pelvic radiotherapy (EBRT) had better quality of life (QOL) outcomes when the combined prostate brachytherapy boost had a high dose rate (HDR), according to research presented here. In a randomized phase III trial comparing health-related QOL outcomes after either low dose rate […]
Far Fewer Deaths During Omicron for Seniors Treated With Paxlovid
Older patients treated with nirmatrelvir boosted by ritonavir (Paxlovid) for COVID-19 had lower rates of hospitalization and death compared with those not treated with the antiviral during the Omicron wave, according to an observational retrospective cohort study from Israel. Among patients ages 65 and older, the rate of hospitalization due to COVID was 14.7 cases […]
Cronobacter Infection: How to Treat
Antibiotics are typically the first line of treatment for Cronobacter infections Cronobacter infections are often treated with antibiotics, typically cefazolin and amoxicillin, which are quite effective in most cases. However, treatment can be challenging because continued use of antibiotics can lead to the development of antibiotic resistance. What are the treatment options for Cronobacter infections? […]
Disordered Eating vs. Eating Disorders: What’s the Difference?
If not treated properly, disordered eating can lead to an eating disorder While an eating disorder is a clinical diagnosis, disordered eating is an unhealthy eating pattern or behavior that does not meet the criteria for an eating disorder diagnosis. All people with eating disorders start with disordered eating, but not everyone with disordered eating […]
Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancer
CHICAGO — Patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan (Enhertu) achieved significant improvements in survival compared with those treated with chemotherapy alone, according to results from the DESTINY-Breast04 Trial. In the phase III international study, among a population of 494 patients with both HR-positive disease (88.7%) and HR-negative disease (11.3%), the risk […]
How Is Substance-Induced Psychosis Treated? Drug Abuse Symptoms
Substance-induced psychosis is initially treated by cessation of the substance causing psychosis and the following treatment plans. The initial treatment for substance-induced psychosis is the cessation of the substance that causes psychosis and monitoring the person in a safe and calm environment. Some of the drugs commonly prescribed for the treatment of substance-induced psychosis include: […]
ART-Free Strategy Could Control HIV in Some African Kids
Roughly half of young children with HIV in Botswana treated with two broadly neutralizing antibodies (bNAbs) were able to remain virally suppressed for 24 weeks, even in the absence of antiretroviral therapy (ART), a researcher said. In a small proof-of-concept study of 25 children ages 2-5 years, 11 children (44%, 95% CI 24%-65%) who stopped […]